Cardio Diagnostics
CDIO
35 hedge funds and large institutions have $55.2M invested in Cardio Diagnostics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
17% more funds holding
Funds holding: 30 → 35 (+5)
11% more capital invested
Capital invested by funds: $49.6M → $55.2M (+$5.59M)
0.42% less ownership
Funds ownership: 2.7% → 2.28% (-0.42%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
+$1.98M |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$1.22M |
| 3 |
MSU
Mizuho Securities USA
New York
|
+$532K |
| 4 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
+$496K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$426K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$2.48M |
| 2 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$6.55K |
| 3 |
KIM
Karpus Investment Management
Pittsford,
New York
|
-$3.87K |
CDIO Hedge Fund Activity: Q2 2022 in Review
35 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Cardio Diagnostics (CDIO) for Q2 2022, worth a combined $55.2M — up 11% from $49.6M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CDIO positions and 0 closed out — a net gain of 5 holders — while 6 added to existing stakes and 3 trimmed.
The largest buyer was Yakira Capital Management, opening a new position worth an estimated $1.98M. The largest seller was Weiss Asset Management, cutting an estimated $2.48M.
- 35 institutional investors held Cardio Diagnostics (CDIO) as of Q2 2022, up from 30 in Q1 2022.
- Funds reported $55.2M of Cardio Diagnostics stock for Q2 2022, up 11% quarter-over-quarter.
- 5 funds opened new Cardio Diagnostics positions in Q2 2022 and 0 closed out, a net change of +5 holders.
- The largest Cardio Diagnostics buyer in Q2 2022 was Yakira Capital Management, an estimated $1.98M added.
- The largest Cardio Diagnostics seller in Q2 2022 was Weiss Asset Management, an estimated $2.48M sold.
Based on aggregated 13F filings for Q2 2022.